Transgenic mice of the RR strain express a receptor recognizing the autoantigen myelin oligodendrocyte glycoprotein (MOG) on most of their T cells and develop an inflammatory demyelinating CNS disease that recapitulates the early stage of human MS. The gene discussed is MOG; the disease is myeloid sarcoma.